BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Dec 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-12-01

Reporting Person: Mueller Brian (VP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-01	Common Stock	M	521	$14.39	Acquired	5114	Direct
2014-12-01	Common Stock	M	6429	$21.51	Acquired	11543	Direct
2014-12-01	Common Stock	S	6950	$90.25	Disposed	4593	Direct
2014-12-02	Common Stock	M	5000	$28.23	Acquired	9593	Direct
2014-12-02	Common Stock	S	5000	$91.82	Disposed	4593	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-01	Stock Option (right to buy Common Stock)	$14.39	M	521	Disposed	2019-05-11	Common Stock (521)	Direct
2014-12-01	Stock Option (right to buy Common Stock)	$21.51	M	6429	Disposed	2020-05-11	Common Stock (6429)	Direct
2014-12-02	Stock Option (right to buy Common Stock)	$28.23	M	5000	Disposed	2021-05-31	Common Stock (5000)	Direct

Footnotes

F1: All shares sold at same price

F2: The price in column 4 is a weighted average price. The price actually received ranged from $91.74 to $91.90. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range

F3: Original option grant vests 6/48th on November 12, 2009, and 1/48th on the 12th day of every month thereafter.

F4: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

F5: Original option grant vests 6/48th on November 12, 2010, and 1/48th on the 12th day of every month thereafter.

F6: Original option grant vests 6/48th on November 30, 2011, and 1/48th on the 11th day of every month thereafter.